Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Sets Teleconference to Discuss FY2017 Results

Global life sciences company Pressure BioSciences, Inc. (OTCQB: PBIO) this morning announced that it plans to host a teleconference to discuss its fourth quarter and fiscal year 2017 financial results and to provide a business update. The teleconference is scheduled for Tuesday, April 3, 2018, at 4:30 PM EDT. Those interested in participating in the call can do so live by dialing (877) 407-8031 in North America or (201) 689-8031 from international locations. The verbal passcode for the teleconference is ‘PBI Fourth Quarter and FY2017 Financial Call & Business Update’. A replay of the call will be made available beginning Wednesday, April 4, 2018, for those unable to participate in the live teleconference. This replay will be accessible via telephone and the company’s website for 30 days. The replay will be reviewable by dialing (877) 481-4010 in North America or (919) 882-2331 from international locations, using replay ID number 27377.

To view the full press release, visit http://ibn.fm/jciYv

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. For more information, visit the company’s website at www.PressureBiosciences.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

This entry was posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO. Bookmark the permalink.

Comments are closed.